Adaptive Biotechnologies Announces New Data Demonstrating :

Data being presented at the 17th European Crohn’s and Colitis Organisation (ECCO) exhibit the use of Adaptive’s ImmunoSEQ® technology to successfully...

Related Keywords

Paris , France General , France , Laura Cooper , Harlan Robins , Carrie Mendivil , Karina Calzadilla , Gastroenterol Hepatol , Exchange Commission , Department Of Gastroenterology , Adaptive Biotechnologies Corporation Nasdaq , Gilmartin Group , Colitis Organisation , Microsoft , European Crohn , Biotechnologies Corporation , Matthieu Allez , Hospital Saint Louis , Chief Scientific Officer , Immune Medicine , Minimal Residual Disease , Financial Condition , Inflammatory Bowel Disease , Linkingt Cell Subsets , Disease Activity , Journal Crohn , Diagnostic Delay , Associated Factors , Clinical Outcomes , Bowel Disease , Inflammatory Bowel , Global Burden , Disease Study , Vice President , Nasdaq Adpt , Adaptive Biotechnologies , Crohnsdisease , Iagnostics , Mmunemedicine ,